Cite
HARVARD Citation
Dohan, A. et al. (2020). Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab. Gut. 69 (3), pp. 531-539. [Online].